Four PTEN‐targeting co‐expressed miRNAs and ACTN4‐ targeting miR‐548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Cancer

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.30915PMID 28779483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.

  2017cited by this paper
• Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

  2016cited by this paper
• MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway

  2016cited by this paper
• AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.

  2015cited by this paper
• Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma.

  2015cited by this paper
• AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

  2015cited by this paper
• Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke

  2015cited by this paper
• MicroRNA biogenesis pathways in cancer

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• miRWalk2.0: a comprehensive atlas of microRNA-target interactions

  2015cited by this paper
• Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay

  2015cited by this paper
• The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer

  2014cited by this paper
• Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer

  2014cited by this paper
• Prognostic Role of miR-205 in Early-Stage (T1N0) Non-Small Cell Lung Cancer

  2014cited by this paper
• MicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinoma.

  2014cited by this paper
• MicroRNA-103 Promotes Colorectal Cancer by Targeting Tumor Suppressor DICER and PTEN

  2014cited by this paper
• Mutational landscape and significance across 12 major cancer types

  2013cited by this paper
• The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease

  2013cited by this paper
• miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.

  2013cited by this paper
• MicroRNA-17-92 Cluster Mediates the Proliferation and Survival of Neural Progenitor Cells after Stroke*

  2013cited by this paper
• miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.

  2013cited by this paper
• Targeting the PI3K/AKT/mTOR pathway: biomarkers of success and tribulation.

  2013cited by this paper
• Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

  2013cited by this paper
• Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib

  2013influential reference
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN

  2012cited by this paper
• miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.

  2012cited by this paper
• Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation

  2012cited by this paper
• A gene expression profile for non-smoking and non-drinking patients with head and neck cancer.

  2012cited by this paper
• Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

  2012cited by this paper
• Axl Is a Prognostic Marker in Oral Squamous Cell Carcinoma

  2012cited by this paper
• Everolimus for Advanced Pancreatic Neuroendocrine Tumors

  2012cited by this paper
• miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes

  2011cited by this paper
• Everolimus for advanced pancreatic neuroendocrine tumors.

  2011cited by this paper
• Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years.

  2011cited by this paper
• RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.

  2010cited by this paper
• Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals.

  2010cited by this paper
• A MicroRNA targeting dicer for metastasis control.

  2010cited by this paper
• AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.

  2009cited by this paper
• Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues

  2009cited by this paper
• Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis

  2009cited by this paper
• Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues

  2009cited by this paper
• Platinum-based chemotherapy plus cetuximab in head and neck cancer.

  2008cited by this paper
• Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

  2007cited by this paper
• A retrovirus-based protein complementation assay screen reveals functional AKT1-binding partners

  2006cited by this paper
• Tongue and tonsil carcinoma

  2005cited by this paper
• Loss of PTEN expression as a prognostic marker for tongue cancer.

  2001cited by this paper
• Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge.

  2001cited by this paper
• PTEN: a tumour suppressor that functions as a phospholipid phosphatase.

  1999cited by this paper
• Improved survival in the treatment of squamous carcinoma of the oral tongue.

  1993cited by this paper
• Cancer statistics

  1989cited by this paper
• Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts

  1972cited by this paper

• MicroRNA- 103 as a novel potential biomarker of poor prognosis and durg resistance in solid tumours

  2025cites this paper
• CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology

  2024cites this paper
• MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis

  2024cites this paper
• The meta-signature guided investigation of miRNA candidates as potential biomarkers of oral cancer.

  2022cites this paper
• miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression

  2022cites this paper
• Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis

  2022influential citation
• A novel regQTL-SNP and the risk of lung cancer: a multi-dimensional study

  2021cites this paper
• Clinical Theragnostic Relationship between Chemotherapeutic Resistance, and Sensitivity and miRNA Expressions in Head and Neck Cancers: A Systematic Review and Meta-Analysis Protocol

  2021cites this paper
• miR-548b Suppresses Melanoma Cell Growth, Migration, and Invasion by Negatively Regulating Its Target Gene HMGB1

  2021cites this paper
• Development of biomarkers for predicting recurrence by determining the metastatic ability of cancer cells.

  2021cites this paper
• MicroRNA-182-5p and microRNA-205-5p as potential biomarkers for prognostic stratification of p16-positive oropharyngeal squamous cell carcinoma

  2021cites this paper
• Diagnostic and therapeutic role of microRNAs in oral cancer

  2020cites this paper
• Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset

  2020cites this paper
• Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.

  2020cites this paper
• MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review

  2020cites this paper
• Actinin-4 Expression Predicts Poor Disease-free Survival and Correlates with Delayed Lymph Node Metastasis in Patients with Completely Resected Oral Squamous Cell Carcinoma.

  2020cites this paper
• Integrated analysis of lncRNAs and mRNAs reveals key trans-target genes associated with ETEC-F4ac adhesion phenotype in porcine small intestine epithelial cells

  2020cites this paper
• The Mechanobiome: A Goldmine for Cancer Therapeutics.

  2020influential citation
• KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer.

  2020cites this paper
• Predictive biomarker for efficient adjuvant therapies by evaluating metastatic ability

  2020cites this paper
• Trophoblastic proliferation and invasion regulated by ACTN4 is impaired in early onset preeclampsia

  2019cites this paper
• MicroRNA-548b inhibits proliferation and invasion of hepatocellular carcinoma cells by directly targeting specificity protein 1.

  2019cites this paper
• Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis

  2019influential citation
• microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA

  2019cites this paper
• MiR-421 expression independently predicts unfavorable overall survival in patients with esophageal adenocarcinoma.

  2019cites this paper